PillLabeler · US market
SAMSUNG BIOLOGICS Co., Ltd.
SAMSUNG BIOLOGICS Co., Ltd. is a US drug labeler with US FDA registrations covering 45 drug concepts (45 currently active) across 64 packages. It is currently the only active US supplier of 27 drugs.
ACTIVE — US
openFDA · updated weekly
Labeler codes71124
Active drugs45
Registrations57 active / 57
Packages64
Sole supplier of27 drugs
Portfolio45 drugs · US
Every drug concept this labeler has US registrations for, by package count.
| Drug | Type | NDCs | Packages | Status |
|---|---|---|---|---|
| Rituximab liquid | other | 2 | 4 | SUPPLYING |
| Emicizumab solution | other | 4 | 4 | SUPPLYING |
| Infliximab liquid | other | 2 | 3 | SUPPLYING |